Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
OMAHA, Neb. (WOWT/Gray News) - A Nebraska woman has become the first patient in the world to undergo a groundbreaking new treatment for multiple sclerosis. Seven years ago, Jan Janisch-Hanzlik began ...
RIVERSIDE, N.J. (WPVI) -- A multiple sclerosis diagnosis used to mean a future of disability. But now, a revolution in medications allows MS patients to pursue their dreams. Those medications are ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational medicine ocrelizumab (OCREVUSTM ...
The faster patients can be diagnosed with multiple sclerosis, the sooner they can begin taking the powerful medications that ...
MENLO PARK, Calif. and CINCINNATI, Dec. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole-genome testing and polygenic risk modelling (PRS) company, today announced a strategic partnership with ...
Jan Janisch-Hanzlik, Dr. Matthew Lunning and Dr. Rana Zabad discuss new multiple sclerosis therapy during a press conference at the Buffett Cancer Center in Omaha on Tuesday, Aug. 5, 2025. When the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback